Bionik Laboratories announced that CEO and board member Eric Dusseux has resigned and Rich Russo, Jr. will assume the role of interim CEO.
Dusseux announced today that he is stepping down to pursue opportunities outside of the rehabilitation robotic device industry.
“This was a difficult decision that I reached after much reflection. It has been a privilege working as CEO, shoulder-to-shoulder with the best team in the business since September 2017. I am proud of all we have accomplished together to serve our patients and clients. I want to thank the team and the Board of Directors for their support,” Dusseux said in a news release.
Chief financial officer Russo will serve as the interim CEO while the Toronto-based company searches for a permanent successor.
“On behalf of the Board, we thank Eric for his service and many accomplishments during his tenure as CEO, particularly during the COVID-19 pandemic. The company has made great strategic, commercial and operational progress under Eric’s leadership. We wish Eric the very best,” chairperson of the board André Auberton-Herve said. “Eric has assembled a talented and highly capable leadership team, including Rich Russo who will step in as Interim CEO. This will ensure continuity while we conduct a search for a permanent replacement.”